Latest News and Press Releases

EWING, N.J., May 27, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Jefferies Virtual...

First Quarter 2020 Revenue $33.1 Million, a 42% Increase Compared to First Quarter 2019 Generated $5.6 Million in Cash from Operations during the First Quarter 2020 EWING, N.J., May 05, 2020 ...

EWING, N.J., April 28, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its first quarter 2020 financial results and recent operating progress before the...

Record Quarterly Revenue of $37.8 Million – Earnings Per Share of $0.03 Record Annual Revenue of $123.9 Million, a 95% Increase over 2018 Annual Revenue EWING, N.J., March 03, 2020 (GLOBE...

EWING, N.J., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the Cowen and Company...

EWING, N.J., Feb. 25, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced it will release its fourth quarter and full year 2019 financial results and recent operating...

EWING, N.J., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (The Company) today announced 2020 full-year net revenue guidance of $135 to $155 million, which includes a range...

EWING, N.J., Dec. 10, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced the appointment of Edward Tykot to the position of Senior Vice President, Corporate Development....

EWING, N.J., Dec. 06, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) (“Antares”) (“the Company”) today announced that the Company’s social media campaign for XYOSTED®, has been honored...

EWING, N.J., Nov. 27, 2019 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ: ATRS) today announced that Robert F. Apple, President and Chief Executive Officer, will present at the 31st Annual Piper...